Collins Stewart initiates coverage on Auxilium Pharmaceuticals Inc. (Nasdaq: AUXL) with a Buy rating and $49 price target, sying Xiaflex ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE